BSE filing, NSE: WILLAMAGOR. Summary written from the filing by ALFA Finder's alert engine.
Williamson Magor & Company Ltd: key numbers
- Share price
- ₹20.14
- Market cap
- ₹22.07 Cr
- Revenue (annual)
- ₹1.54 Cr
- Net profit (annual)
- ₹-1.26 Cr
- P/E (TTM)
- -1.4×Sector 19.7×
- Promoter holding
- 62.01%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Williamson Magor & Company Ltd
All →Williamson Magor & Company Management Change
Williamson Magor & Company Limited announced a change in the designation of directors Arup Pal and Subhajit Majumdar.
Williamson Magor & Company Annual General Meeting
Williamson Magor & Co. held its 75th Annual General Meeting on 28th September 2026. The meeting transacted ordinary business, including approval of financial statements and director appointments.
Williamson Magor & Company Other Announcement
Williamson Magor informed the exchange regarding the dispatch of letters to shareholders containing the web-link to access the Annual Report for FY 2025-26.
Williamson Magor & Company Annual Report
Williamson Magor & Co. Limited has filed its Annual Report for the financial year ended 31st March, 2026, with the stock exchanges.
Williamson Magor & Company Annual General Meeting
Williamson Magor & Co. Limited has scheduled its 75th Annual General Meeting for September 28, 2026. The meeting will be held via video conferencing.
Williamson Magor & Company Q1 FY27 Results: Net Loss of ₹12.5 Cr
Williamson Magor & Company Ltd reported a net loss of ₹12.5 Cr for Q1 FY27.
- Key figure
- Net loss ₹12.5 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.